ConductScience.org, home

85,013 comparisons from ClinicalTrials.gov. Counted 2026-11-10.

85,013 comparisons

Most participants first33,758 with no events in either group come last121 to 140 of 85,013

Show the results as
ComparisonWith the outcomeRisk difference, 95% intervalParticipantsTrial
E-MOTIVE Intervention vs Usual Care: Number of Women With Laparotomy With Compression Sutures Postpartum Until Discharge From the Health Facility1 of 49,101

1 of 50,558

0.0 points

-0.0 to 0.0

99,659NCT04341662

A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth

E-MOTIVE Intervention vs Usual Care: Number of Women With Hysterectomy Postpartum Until Discharge From the Health Facility11 of 49,101

6 of 50,558

0.0 points

-0.0 to 0.0

99,659NCT04341662

A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth

E-MOTIVE Intervention vs Usual Care: Number of Women With Laparotomy Postpartum Until Discharge From the Health Facility13 of 49,101

9 of 50,558

0.0 points

-0.0 to 0.0

99,659NCT04341662

A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth

E-MOTIVE Intervention vs Usual Care: The Primary Outcome is a Composite of the Following Three Clinical Outcomes: 1) Severe PPH Defined as Blood Loss ≥1000 ml or; 2) Postpartum Laparotomy for Bleeding or; 3) Postpartum Maternal Death From Bleeding. Please See Below for Further Details.794 of 49,101

2,139 of 50,558

-2.6 points

-2.8 to -2.4

99,659NCT04341662

A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth

E-MOTIVE Intervention vs Usual Care: Number of Women Admitted to Intensive Care Unit (ICU) Until Discharge From the Health Facility7 of 49,101

32 of 50,558

-0.0 points

-0.1 to -0.0

99,659NCT04341662

A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth

E-MOTIVE Intervention vs Usual Care: Number of Women With Hysterectomy for Bleeding Postpartum Until Discharge From the Health Facility9 of 49,101

6 of 50,558

0.0 points

-0.0 to 0.0

99,659NCT04341662

A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth

E-MOTIVE Intervention vs Usual Care: deaths from any cause17 of 49,101

28 of 50,558

-0.0 points

-0.0 to 0.0

99,659NCT04341662

A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth

E-MOTIVE Intervention vs Usual Care: Postpartum Laparotomy for Bleeding Until Discharge From the Health Facility12 of 49,101

7 of 50,558

0.0 points

-0.0 to 0.0

99,659NCT04341662

A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth

E-MOTIVE Intervention vs Usual Care: serious adverse events7 of 49,101

32 of 50,558

-0.0 points

-0.1 to -0.0

99,659NCT04341662

A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth

PRIM-ER vs Control: deaths from any cause13,910 of 48,464

14,179 of 50,458

0.6 points

0.0 to 1.2

98,922NCT03424109

Primary Palliative Care for Emergency Medicine (PRIM-ER)

Point of Care vs Direct Patient Engagement: Rates of Testing757 of 51,693

717 of 43,930

-0.2 points

-0.3 to -0.0

95,623NCT04746794

Early Detection of GEnetic Risk (EDGE)

Point of Care vs Direct Patient Engagement: Rates of Screening9,892 of 51,693

3,813 of 43,930

10.5 points

10.0 to 10.9

95,623NCT04746794

Early Detection of GEnetic Risk (EDGE)

Intervention Arm Stage 1 vs Intervention Arm Stage II: deaths from any cause1,217 of 79,818

18 of 5,447

1.2 points

1.0 to 1.3

85,265NCT01864603

Sustainable East Africa Research in Community Health

13vPnC vs Placebo: Number of Participants With First Episode of Nonbacteremic/Noninvasive (NB/NI) Vaccine-type Community-acquired Pneumonia (VT-CAP)33 of 42,240

60 of 42,256

-0.1 points

-0.1 to -0.0

84,496NCT00744263

Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults

13vPnC vs Placebo: Number of Participants With First Episodes of Vaccine-type Invasive Pneumococcal Disease (VT-IPD) Cases7 of 42,240

28 of 42,256

-0.0 points

-0.1 to -0.0

84,496NCT00744263

Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults

13vPnC vs Placebo: Number of Participants With First Episode of Confirmed Vaccine-type Community-acquired Pneumonia (VT-CAP)49 of 42,240

90 of 42,256

-0.1 points

-0.2 to -0.0

84,496NCT00744263

Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults

PCV13-vaccinated Participants vs Unvaccinated Participants: VE for First Event of IPD at 5-7 Years of Follow-up32 of 31,770

54 of 48,523

-0.0 points

-0.1 to 0.0

80,293NCT05794191

A Study To Learn About The Effects Of Pneumococcal Vaccine In People With HIV

Intervention vs Control: serious adverse events1 of 52,526

0 of 27,513

0.0 points

-0.0 to 0.0

80,039NCT06057727

Behavioral Economics to Improve Flu Vaccination Using EHR Nudges

PCV13-vaccinated Participants vs Unvaccinated Participants: VE for First Event of PP at 5-7 Years of Follow-up49 of 31,660

69 of 48,369

0.0 points

-0.0 to 0.1

80,029NCT05794191

A Study To Learn About The Effects Of Pneumococcal Vaccine In People With HIV

Anesthesia Control Tower Monitoring vs Standard of Care Arm: deaths from any cause866 of 39,810

899 of 39,750

-0.1 points

-0.3 to 0.1

79,560NCT03923699

Telemedicine Control Tower for the Operating Room: Navigating Information, Care and Safety

Request

GET /api/comparisons/v1

Words from a trial's title, conditions or interventions, its outcome or its groups, or an NCT number.

An outcome counted in participants, the serious adverse events, or the deaths from any cause.

No key needed

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=7

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT04341662-91b919c1",
        "title": "E-MOTIVE Intervention vs Usual Care: Number of Women With Laparotomy With Compression Sutures Postpartum Until Discharge From the Health Facility",
        "summary": "1 of 49101 against 1 of 50558; risk difference 0.0 points, 95% interval -0.0 to 0.0; NCT04341662, A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth",
        "record": "/library/comparisons/NCT04341662-91b919c1",
        "nct_id": "NCT04341662",
        "kind": "outcome",
        "participants": 99659,
        "risk_difference": {
          "value": 5.869205678759168e-7,
          "lower": -0.00009318518695442179,
          "upper": 0.0000969706999198734
        },
        "group_1": "1 of 49,101",
        "group_2": "1 of 50,558",
        "difference": "0.0 points",
        "interval": "-0.0 to 0.0",
        "trial_title": "A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth"
      },
      {
        "id": "NCT04341662-96369f81",
        "title": "E-MOTIVE Intervention vs Usual Care: Number of Women With Hysterectomy Postpartum Until Discharge From the Health Facility",
        "summary": "11 of 49101 against 6 of 50558; risk difference 0.0 points, 95% interval -0.0 to 0.0; NCT04341662, A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth",
        "record": "/library/comparisons/NCT04341662-96369f81",
        "nct_id": "NCT04341662",
        "kind": "outcome",
        "participants": 99659,
        "risk_difference": {
          "value": 0.00010535244334778625,
          "lower": -0.00006626934917397676,
          "upper": 0.0002937776938744959
        },
        "group_1": "11 of 49,101",
        "group_2": "6 of 50,558",
        "difference": "0.0 points",
        "interval": "-0.0 to 0.0",
        "trial_title": "A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "None stated"
    }
  ],
  "next": "/api/comparisons/v1?page=8",
  "request_id": "FF0-uiJum3dmlJod"
}
trial-comparisons-2026-03-23-0.1.0Next page

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

Genes

NCBI Gene

One gene with its proteins, patents, drugs, trials, grants and papers.

Open193,990 genes2026-11-11

Trials

ClinicalTrials.gov

Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.

Open611,552 trials2026-11-12

Sequences

Patent publications

Paste a sequence and see the patents that disclose it.

For invited accounts.

Opens sequences.conductscience.org

By invitation39,249,078 sequences2026-11-05

For software

Read Trial comparisons from software.

Every answer on this page is also JSON, under /api/comparisons/v1. No key.

GET https://conductscience.org/api/comparisons/v1?q=placebo%20heart%20failure&kind=outcome

Ask an assistant

  • In FOURIER, how did serious adverse events compare between evolocumab and placebo?
  • Which metformin trials reported deaths, and what was the risk difference?
  • What was the number needed to treat for HELIOS-B's composite outcome?
  • Which placebo-controlled heart failure trials had the most participants?